Nowon Samsung Orthopedic Clinic Directors Lee Semin and Kim Gyeongil Give a 'CARTISTEM' Lecture at MEDIPOST's Invitation
CARTISTEM application strategies based on actual cases presented... Plaques of appreciation presented as academic exchange on stem cell-based cartilage treatment expands
MEDIPOST (CEOs Min Hoseong and Oh Wonil) said on November 2 that it had held a lecture on October 23, inviting Lee Semin, director of Nowon Samsung Orthopedic Clinic in Nowon-gu, Seoul, and Kim Gyeongil, the clinic’s chief director, to share their clinical experience and surgical techniques in using CARTISTEM®, a treatment for knee cartilage defects. The company also presented the two doctors with plaques of appreciation.
The lecture was based on actual cases involving patients with knee cartilage defects. The two doctors explained the criteria for using CARTISTEM, an allogeneic umbilical cord blood-derived mesenchymal stem cell therapy, and the surgical techniques involved, highlighting specific factors that require clinical judgment. They discussed, in turn, how to develop a surgical strategy based on the extent and location of cartilage damage, degenerative changes in the joint, and lower-limb alignment; how to prepare the cartilage defect site; how to apply the treatment; and how to manage postoperative rehabilitation and follow-up.
The two doctors emphasized that when determining a treatment plan, clinicians should consider not only a patient's age and level of pain but also the characteristics of the cartilage defect and the condition of the joint as a whole.
MEDIPOST, a global leader in stem cell biotechnology, described the lecture as an opportunity for the company that developed the treatment and the medical professionals who perform the surgeries to share their experience. The plaques expressed appreciation for the two doctors' contributions to academic exchange. A MEDIPOST representative said the company regularly creates opportunities to share treatment experience gained in clinical practice. The representative added that the company would continue sharing clinical expertise and engaging in academic exchange to "improve patient outcomes and further strengthen cooperation in stem cell research and education."
This underscores the need to actively share not only the underlying technology behind treatments but also surgical expertise accumulated in clinical practice and experience in long-term follow-up.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Lee Semin, who led the lecture, is an orthopedic surgeon and doctor of medicine who treats knee joint conditions and sports injuries. Kim Gyeongil, the clinic's chief director, is an orthopedic surgeon formerly with Sanggye Paik Hospital and works in both nonsurgical and surgical treatment of various joint conditions. Nowon Samsung Orthopedic Clinic, led by the two doctors, has built up clinical experience with CARTISTEM while providing care tailored to each patient's condition, from diagnosis of knee joint conditions through nonsurgical treatment, surgery, and rehabilitation. The clinic is equipped with diagnostic imaging systems, including two MRI machines, as well as a joint surgery center and a rehabilitation and performance center.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.